Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss

  title={Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss},
  author={A. Yassin and G. Doros},
  journal={Clinical Obesity},
  pages={73 - 83}
  • A. Yassin, G. Doros
  • Published 2013
  • Medicine
  • Clinical Obesity
  • Hypogonadism is associated with increased fat mass and reduced muscle mass, which contributes to obesity and health risks, such as cardiovascular disease. Testosterone treatment of hypogonadal men improves muscle mass and reduces fat mass; however, many of these studies are of short duration. Thus, the long‐term effects of testosterone on body anthropometry are not known. 
    81 Citations

    Paper Mentions

    Metabolic syndrome and hypogonadism--two peas in a pod.
    • 15
    • PDF
    Testosterone and weight loss: the evidence
    • A. Traish
    • Medicine
    • Current opinion in endocrinology, diabetes, and obesity
    • 2014
    • 61
    Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy
    • 22
    THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study.
    • 103
    • PDF


    Long‐term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss
    • 128
    • Highly Influential
    • PDF
    Testosterone as Potential Effective Therapy in Treatment of Obesity in Men with Testosterone Deficiency: A Review
    • 115
    • PDF
    Testosterone and cardiovascular disease: an old idea with modern clinical implications.
    • 64
    Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
    • F. Saad
    • Medicine
    • Diabetes/metabolism research and reviews
    • 2012
    • 35
    Testosterone deficiency.
    • 100
    • PDF
    The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
    • P. Marin, S. Holmäng, +5 authors P. Björntorp
    • Medicine
    • International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity
    • 1992
    • 570
    • PDF
    Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
    • 251
    • PDF